Cancer, chemotherapy and pharmacology
CCP
| LEADER | cas a22 4 4500 | ||
|---|---|---|---|
| 001 | 134278739 | ||
| 003 | CHVBK | ||
| 005 | 20201015102739.0 | ||
| 008 | 990819d19782017gw || p|| 0 |0und|d | ||
| 016 | 7 | |a 68202 |2 ZDB | |
| 022 | |l 0344-5704 | ||
| 022 | |a 0344-5704 | ||
| 035 | |a (OCoLC)612058047 | ||
| 035 | |a (NEBIS)000980286 | ||
| 040 | |a ZBZ |b ger |d SzZuIDS NEBIS ETH-BIB |e rda | ||
| 082 | 0 | 4 | |a 616.994061 |2 22 |
| 082 | 1 | 4 | |a 616.994005 |2 22 |
| 210 | 1 | |a Cancer Chemother Pharmacol | |
| 245 | 0 | 0 | |a Cancer, chemotherapy and pharmacology |b CCP |
| 246 | 1 | 0 | |a CCP |
| 264 | 1 | |a Heidelberg |b Springer |c 1978-2017 | |
| 300 | |a Bände | ||
| 310 | |a Monatlich | ||
| 336 | |a Text |b txt |2 rdacontent/ger | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia/ger | ||
| 338 | |a Band |b nc |2 rdacarrier/ger | ||
| 362 | 0 | |a Volume 1, issue 1 (March 1978)-Volume 80, issue 6 (Dec. 2017) | |
| 500 | |a Erscheint ab 2018 nur online | ||
| 524 | |a CCAP |2 O | ||
| 650 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd | |
| 650 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd | |
| 650 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd | |
| 650 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd | |
| 650 | 7 | |a Tumorhemmstoff |0 (DE-588)4292869-2 |2 gnd | |
| 650 | 7 | |a Zeitschrift |0 (DE-588)4067488-5 |2 gnd | |
| 650 | 7 | |a KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE) |x ger |0 (ETHUDK)000026738 |2 ethudk | |
| 650 | 7 | |a THERAPEUTISCHE PHARMAKOLOGIE, VERABREICHUNG VON ARZNEIMITTELN, CHEMOTHERAPIE, KLINISCHE PHARMAKOLOGIE |x ger |0 (ETHUDK)000026636 |2 ethudk | |
| 650 | 7 | |a TUMOREN + ONKOLOGIE + KREBS (MEDIZIN) |x ger |0 (ETHUDK)000026970 |2 ethudk | |
| 655 | 7 | |a Zeitschrift |2 gnd-content | |
| 691 | 7 | |B u |a TUMOREN + ONKOLOGIE + KREBS (MEDIZIN) |z ger |u 616-006 |2 nebis E1 | |
| 691 | 7 | |B u |a THERAPEUTISCHE PHARMAKOLOGIE, VERABREICHUNG VON ARZNEIMITTELN, CHEMOTHERAPIE, KLINISCHE PHARMAKOLOGIE |z ger |u 615.03 |2 nebis E1 | |
| 691 | 7 | |B u |a KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE) |z ger |u 615.277.3 |2 nebis E1 | |
| 691 | 7 | |B u |a TUMEURS + ONCOLOGIE + CANCER (MÉDECINE) |z fre |u 616-006 |2 nebis E1 | |
| 691 | 7 | |B u |a TUMOURS + ONCOLOGY + CANCER (MEDICINE) |z eng |u 616-006 |2 nebis E1 | |
| 691 | 7 | |B u |a CLINICAL PHARMACOLOGY, THERAPEUTICAL PHARMACOLOGY, CHEMOTHERAPY, MEDICATION, ADMINISTRATION OF DRUGS |z eng |u 615.03 |2 nebis E1 | |
| 691 | 7 | |B u |a PHARMACOLOGIE THÉRAPEUTIQUE, APPLICATION DE MÉDICAMENTS, CHIMIOTHÉRAPIE, PHARMACOLOGIE CLINIQUE |z fre |u 615.03 |2 nebis E1 | |
| 691 | 7 | |B u |a CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY) |z eng |u 615.277.3 |2 nebis E1 | |
| 691 | 7 | |B u |a ONCOSTATIQUES + CARCINOSTATIQUES + ANTINÉOPLASTIQUES (PHARMACIE) |z fre |u 615.277.3 |2 nebis E1 | |
| 852 | 4 | |B NEBIS |F CHSBK |b Z0SBK |c ZBKOL |j UE 1003 |a 1(1978)-62(2008) | |
| 897 | |a b |b 4 | ||
| 898 | |a CR030600 |b XR030000 |c XR030000 | ||
| 909 | 7 | |a noselfmerge |2 ids I | |
| 912 | 7 | |a 130 |2 E01 | |
| 986 | |a SWISSBIB |b 120719282 | ||